Literature DB >> 12359100

Lyme disease.

Patricia K Coyle1.   

Abstract

Lyme disease is due to infection with a tick-borne spirochete, Borrelia burgdorferi. Risk for infection is confined to regions that contain the Ixodid tick vector. Characteristic skin, musculoskeletal, cardiac, ocular, and neurologic disorders are associated with the local, early dissemination and late stages of infection. Neurologic involvement can be seen at all stages, and involves both central and peripheral nervous system syndromes. The inability to easily culture B. burgdorferi and the lack of a reliable active infection assay have contributed to controversies in diagnosis and management. Because the vast majority of patients are seropositive, however, antibody testing is helpful to support the diagnosis of Lyme disease. With appropriate antibiotics, most patients do well. This infection provides an important model system to understand how interactions between an organism, vector, and host lead to disease. It also provides a model to study how infectious agents lead to neurologic disease.

Entities:  

Mesh:

Year:  2002        PMID: 12359100     DOI: 10.1007/s11910-002-0033-2

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  58 in total

Review 1.  Teratogen update: Lyme disease.

Authors:  D J Elliott; S C Eppes; J D Klein
Journal:  Teratology       Date:  2001-11

Review 2.  Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis.

Authors:  C Thompson; A Spielman; P J Krause
Journal:  Clin Infect Dis       Date:  2001-08-06       Impact factor: 9.079

3.  Cost-effectiveness analysis of the Lyme disease vaccine.

Authors:  Elizabeth C Hsia; James B Chung; J Sanford Schwartz; Daniel A Albert
Journal:  Arthritis Rheum       Date:  2002-06

4.  Diagnostic value of cerebrospinal fluid examination in children with peripheral facial palsy and suspected Lyme borreliosis.

Authors:  M Albisetti; G Schaer; M Good; E Boltshauser; D Nadal
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

5.  Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis.

Authors:  J J Nocton; B J Bloom; B J Rutledge; D H Persing; E L Logigian; C H Schmid; A C Steere
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

6.  Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis.

Authors:  V Thomas; J Anguita; S W Barthold; E Fikrig
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  A first-tier rapid assay for the serodiagnosis of Borrelia burgdorferi infection.

Authors:  M J Gomes-Solecki; G P Wormser; D H Persing; B W Berger; J D Glass; X Yang; R J Dattwyler
Journal:  Arch Intern Med       Date:  2001-09-10

Review 8.  Nervous system Lyme disease.

Authors:  J J Halperin
Journal:  J Neurol Sci       Date:  1998-01-08       Impact factor: 3.181

Review 9.  Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  J J Halperin; E L Logigian; M F Finkel; R A Pearl
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

Review 10.  Lyme disease: an infectious and postinfectious syndrome.

Authors:  E S Asch; D I Bujak; M Weiss; M G Peterson; A Weinstein
Journal:  J Rheumatol       Date:  1994-03       Impact factor: 4.666

View more
  1 in total

1.  Two paralogous families of a two-gene subtilisin operon are widely distributed in oral treponemes.

Authors:  Frederick F Correia; Alvin R Plummer; Richard P Ellen; Chris Wyss; Susan K Boches; Jamie L Galvin; Bruce J Paster; Floyd E Dewhirst
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.